Medical costs are rising, and so are the premiums for health insurance. To tackle this, the Malaysian government is considering introducing a Diagnosis-Related Group pricing system. But is DRG the right prescription for Malaysia’s healthcare woes, or will it create new challenges for hospitals, doctors, and patients alike? On this episode of #ConsiderThis Melisa Idris speaks with Azrul Mohd Khalib, CEO of the Galen Centre for Health and Social Policy.